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A B S T R A C T
Impaired ability to recall specific autobiographical memories is characteristic of depression, which when re-
versed, may have therapeutic benefits. This cluster-randomized controlled pilot trial investigated efficacy and
aspects of acceptability, and feasibility of MEmory Specificity Training (MEST) relative to Psychoeducation and
Supportive Counselling (PSC) for Major Depressive Disorder (N=62). A key aim of this study was to determine
a range of effect size estimates to inform a later phase trial. Assessments were completed at baseline, post-
treatment and 3-month follow-up. The cognitive process outcome was memory specificity. The primary clinical
outcome was symptoms on the Beck Depression Inventory-II at 3-month follow-up. The MEST group demon-
strated greater improvement in memory specificity relative to PSC at post-intervention (d=0.88) and follow-up
(d= 0.74), relative to PSC. Both groups experienced a reduction in depressive symptoms at 3-month follow-up
(d= 0.67). However, there was no support for a greater improvement in depressive symptoms at 3 months
following MEST relative to PSC (d=−0.04). Although MEST generated changes on memory specificity and
improved depressive symptoms, results provide no indication that MEST is superior to PSC in the resolution of
self-reported depressive symptoms. Implications for later-phase definitive trials of MEST are discussed.
1. Introduction
Psychological treatments for depression are effective, yet there is
considerable scope to improve their accessibility. Psychological inter-
ventions such as cognitive-behavioral therapy (CBT) or structured,
supportive counselling can be difficult to access due to availability and
cost. A shortage of skilled mental health professionals who are trained
to deliver these interventions means that 54% of those who require
immediate psychological intervention will spend approximately three
months on a waiting list, with 12% waiting more than one year before
these interventions are received (Docherty & Thornicroft, 2015; Mind,
2013). Depression is the leading cause of disability worldwide (WHO,
2017) and if it is to be better treated, the availability of effective
treatments must be improved. Therefore, further investigation is
needed into novel ‘low intensity’ psychological approaches which can
be delivered by non-specialists and are thereby relatively inexpensive,
and can be easily scaled.
There has been accumulating interest in autobiographical memory
training procedures as one such option for a range of psychological
disorders, including depression (Hitchcock, Werner-Seidler, Blackwell,
& Dalgleish, 2017). Memory training in depression focuses on reversing
memory biases that are characteristic of the disorder in order to bring
about improvements in symptoms, and considerable research (for re-
view see Hitchcock et al., 2017) has focussed on reducing overgeneral
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retrieval of autobiographical memory (OGM). It is well established that
depression is associated with pervasive difficulties in retrieving highly
specific memories of past personal events when prompted (e.g. I enjoyed
John's party last autumn). OGM refers to the tendency for depressed
individuals instead to provide summary categories of repeated events
(e.g., I always drink too much at parties), or extended memories of events
that lasted for a protracted period of time (e.g., Last autumn was a dif-
ficult time for me at work) rather than the required specific memories of
discrete occurrences (Williams et al., 2007). The CaR-FA-X model
outlines three mechanisms which underpin the proclivity to recall
overgeneral memories in depression; Capture and Rumination, Func-
tional Avoidance, and impaired eXecutive control (Williams et al.,
2007). The model suggests that during the search for a specific memory
of an event, attention can be captured by depression-relevant material
that is general in nature, triggering rumination and therefore inter-
rupting the search and preventing the retrieval of the specific in-
formation. The second factor, functional avoidance, proposes that OGM
is an avoidance strategy that serves to mitigate the unwanted affective
impact of recalling specific memories that contain emotionally-dis-
tressing material. The final aspect of the model, executive dysfunction,
proposes that the availability of mental resources required to remain
focused on the memory retrieval task is compromised in depression.
There is empirical support for each component of the model (e.g.,
Dalgleish et al., 2007; Hermans et al., 2008; Watkins & Teasdale, 2001).
OGM causes impairment in everyday functioning due to its asso-
ciation with a range of dysfunctional processes including difficulty
imagining future events (Jing, Madore, & Schacter, 2016), impaired
capacity for problem solving (Goddard, Dritschel, & Burton, 1996), and
difficulties with the sharing of personal material (Beike, Brandon, &
Cole, 2016). Disturbances across these domains appear to have an on-
going negative impact on planning for the future, goal-directed activity,
interpersonal relationships, and subsequently low mood (Williams
et al., 2007). Poor accessibility of specific memories drives the un-
restrained, overgeneralised negative self-judgements which contribute
to worthlessness and hopelessness (Hitchcock, Rees, & Dalgleish, 2017).
Further, the inability to recall emotionally vivid, specific memories of
positive experiences both exacerbates anhedonia and reduces the
ability to repair transient low mood (Joormann & Siemer, 2004). It is
therefore not surprising that OGM is a strong predictor of the course
and chronicity of major depression over and above current symptom
levels (Brittlebank, Scott, Williams, & Ferrier, 1993; Sumner, Griffith, &
Mineka, 2010).
Compromised memory specificity thereby represents a logical and
attractive target for therapeutic intervention. Memory specificity ap-
pears modifiable (Jing et al., 2016; Yeung, Dalgleish, Golden, &
Schartau, 2006); consequently, interventions that improve access to
specific memories should, in theory, provide therapeutic benefit by
ameliorating the adverse consequences associated with OGM
(Hitchcock et al., 2017). Initial support for this hypothesis came from
the finding that a brief (4 session), group-based psychological inter-
vention – MEmory Specificity Training (MEST) – was successful in re-
ducing OGM and ameliorating a number of associated cognitive pro-
cesses in depressed individuals in an uncontrolled clinical trial (Raes,
Williams, & Hermans, 2009). Training simply involved practice in re-
trieving specific memories to a range of cue words, delivered across
four, weekly sessions and complemented by between-session home-
work. Using a pre-post design, results indicated that participants were
more specific in memory retrieval after completing the training, which
was accompanied by improvements in problem solving, rumination,
and hopelessness (Raes et al., 2009). Although this trial was un-
controlled and thus limited by several design factors, it nonetheless
confirmed that, in principle, memory specificity can be trained. A
subsequent single-group pre-post pilot study investigated the feasibility
of delivering MEST in an outpatient setting, and replicated the previous
findings of increased specificity and decreased depressive symptoms
following training (Eigenhuis, Seldenrijk, van Schaik, Raes, & van
Oppen, 2017). Moreover, participants were encouraging of the inter-
vention content and therapists supported the minimal training required
to deliver MEST. These results suggest that the MEST programme is a
feasible approach that can be delivered in an outpatient setting and
could be an efficacious intervention for depression.
A follow-up pilot randomized controlled trial compared the MEST
programme to a no-treatment control condition in a sample of 23 be-
reaved, depressed Afghani teenagers living in Iran (Neshat-Doost et al.,
2013). Replicating findings from the initial uncontrolled study, MEST
improved memory specificity in the experimental group, while speci-
ficity did not change in the control group. Although there were no
symptom differences between conditions immediately following the
programme, at two-month follow-up the MEST group also reported
fewer depressive symptoms than the control group. Notably, changes in
memory specificity from pre-to post-intervention mediated the reduc-
tion in depressive symptoms at follow-up suggesting that memory
specificity was a mechanism involved in the improvement in symptoms.
These preliminary studies support the hypothesis that MEST pro-
duces benefits in terms of memory specificity, with the latter study also
suggesting an effect on depressive symptoms. In accordance with
Medical Research Council guidelines (Craig et al., 2011), once early
phase studies have established a foundation of evidence, larger scale
pilot trials, or platform trials, against an active intervention are needed
to more comprehensively evaluate the intervention. Pilot trials of this
nature ensure the recruitment, assessment, and treatment components
run smoothly, and provide a platform for progression to a fully-pow-
ered, definitive trial (National Institute for Health Research [NIHR],
2017). The current study therefore used a blinded, randomized con-
trolled design to compare MEST to an active intervention – a group
psychoeducation and supportive counselling (PSC) program. The ad-
ministered PSC protocol was derived from a Rogerian humanistic, non-
directive supportive counselling framework (Cooper, O'Hara, Schmid, &
Wyatt, 2007) and combined general psychoeducation about depression
with counselling and support provided by both the group facilitators
and peers. Both supportive counselling and peer support interventions
are regarded as effective for the treatment of adult depression (Cape,
Whittington, Buszewicz, Wallace, & Underwood, 2010; Gibbard &
Hanley, 2008; Jacobs & Reupert, 2014; Pfeiffer, Heisler, Piette, Rogers,
& Valenstein, 2011), with meta-analyses indicating effect sizes between
0.32 and 0.58 relative to usual treatment and non-treatment control
groups (Cape et al., 2010; Cuijpers et al., 2012). The inclusion of an
active comparison condition represents an important advance on pre-
vious MEST studies because it will allow for the range of likely effect
sizes of MEST relative to PSC to be estimated, which can inform design
for a later-phase fully powered trial.
As this was a pilot, platform trial the sample size target (N=60)
was set to allow us estimate the range of likely effect sizes delivered by
MEST, relative to PSC (see the trial protocol; Dalgleish et al., 2014).
This contrasts with a fully-powered definitive trial where the likely
effect sizes have been previously established and sample sizes are set to
provide the statistical power to reject the null hypothesis of no differ-
ence between treatment arms (MRC, 2000). The findings from this trial
can then provide appropriate effect-size estimates for MEST that can be
used for sample-size calculations in later fully-powered definitive trials
(Lancaster, Dodd, & Williamson, 2004).
If MEST turns out to be efficacious it would offer an attractive, ac-
cessible therapeutic option for depression as it is brief (only 5 weeks)
and can be delivered by individuals who have not had as extensive
training as that required for more complex psychological interventions
such as supportive counselling or cognitive behaviour therapy. This is
due to a detailed prescriptive training manual which includes both
therapist and client materials for each session. The treatment does not
require the therapist to challenge or confront maladaptive thinking,
facilitate problem solving, provide counselling, or draw links between,
or reconcile, the past experiences of participants. This makes MEST an
appealing candidate as a low-intensity programme that can be readily
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scaled, and is cheaper and easier to deliver than current psychological
interventions which require considerable training in a variety of ther-
apeutic techniques.
The primary endpoint for this trial was self-reported depressive
symptoms at three months post-treatment following MEST, as com-
pared to PSC. Secondary outcomes were depressive symptoms at post-
intervention, and diagnostic status, depression-free days and memory
specificity at both post and 3-month follow-up, along with diagnostic
status and depression-free days at 6-months for the MEST group only
(as the PSC group were offered MEST at the 3-month point). We also
explored whether any reduction in depressive symptoms was mediated
by change in memory specificity (cf. Neshat-Doost et al., 2013; see the
published trial protocol for details; Dalgleish et al., 2014).
2. Method
This trial was registered at clinicaltrials.gov (#NCT01882452). The
full protocol was published (Dalgleish et al., 2014).
2.1. Trial design
We completed a single-blind, parallel cluster randomized controlled
trial (RCT) comparing MEST to a psychoeducation and supportive
counselling intervention, with an embedded exploratory mechanisms
study. Assessments were conducted at baseline, post-intervention, and
3-month follow-up in both arms, with an additional 6-month follow-up
assessment for the MEST group only. The primary outcome was self-
reported depression at 3 months follow-up.
2.2. Participants
As noted in the Introduction, although a standard power calculation
based on detecting treatment effects would be the conventional ap-
proach to determining sample size for a definitive clinical trial, the
main aim of the current pilot trial was to investigate the likely efficacy
of MEST, in preparation for scaled-up later phase fully-powered eva-
luations of the intervention in line with MRC guidance (MRC, 2000).
We deemed that 60 participants (30 in each arm) would provide suf-
ficient numbers to estimate efficacy, provide an initial indication of
feasibility of the trial procedures and acceptability of the intervention,
and to generate preliminary process data for this treatment. This sample
size would provide 24 patients in each arm, allowing for 20% attrition.
This would provide a plausible range of point estimates of effect on our
set of outcome measures sufficient to guide us in sample size calcula-
tions for later phase trial work (Dalgleish et al., 2014).
Inclusion criteria were a diagnosis of Major Depressive Disorder
(MDD; recurrent) according to the Structured Clinical Interview for the
DSM-IV Axis I Disorders - Clinician Version (First, Spitzer, Gibbon, &
Williams, 1995), a diagnosis of a current Major Depressive Episode
(MDE), together with the presence of moderate symptoms defined on
the Beck Depression Inventory II as > 13 (BDI-II; Beck, Steer, & Brown,
1996), and a level of memory specificity of lower than 70% as assessed
on the Autobiographical Memory Test (AMT; Williams & Broadbent,
1986) during the screening session (see Procedures). A deficit in
memory specificity was a necessary inclusion criterion because, unless
specificity is compromised, there is little opportunity for benefits to
accrue. SCIDs were completed by trained research staff under the su-
pervision of a clinical psychologist (AWS or CH). Scoring on 100% of
SCIDs was second-rated by the clinical psychologist, which resulted in
100% agreement on diagnostic status for primary and comorbid dis-
orders. Exclusion criteria were high levels of suicidal intent (ascer-
tained from the clinical interview and based on clinical judgement),
current symptoms of psychosis or current drug or alcohol abuse or
dependence (all assessed via the SCID-IV), a diagnosed Axis II disorder
(assessed via participant report), or the presence of intellectual dis-
ability or traumatic brain injury (also verified by participant report).
Participants were recruited in three ways. The first pathway was
direct from the community using online and print advertisements.
Interested participants were screened over the phone for previous
mental health problems, current mood difficulties, and brain injury.
Suitable participants were invited into the laboratory to verify study
eligibility. The second pathway was through clinical services offered
within the Cambridgeshire and Peterborough NHS Foundation Trust,
UK. Service-users were identified by the clinical team and provided
with an information sheet about the trial. These individuals opted in by
contacting the research team and were then screened for eligibility as
already described. The final pathway was from our departmental
mental health panel. These individuals had previously responded to
advertisements requesting volunteers with depression to assist with
research. Again, individuals were screened over the phone and suitable
participants were invited in for a screening session to verify eligibility.
2.3. Interventions
2.3.1. MEmory specificity training (MEST)
The original treatment manual (Raes et al., 2009) was translated
from Dutch into English, and was extended from four to five sessions, in
line with the initial pilot RCT (Neshat-Doost et al., 2013). The man-
ualized programme involved two therapists delivering treatment over
5×60min sessions to groups of 5–8 individuals. Between sessions,
participants were required to keep a diary in which they recorded a
specific memory of the day, and completed further cued-recall ex-
ercises.
Over the five sessions, participants practiced recalling specific
memories in response to a range of different cues (words and pictures of
different emotional valence), with weekly homework. Session 1 in-
volved psychoeducation about memory difficulties common in depres-
sion and practice recalling specific memories in response to positive and
neutral cues. Session 2 followed the same format with further practice.
In Session 3, memory retrieval using negative cues was introduced.
Session 4 involved practice to positive, negative, and neutral cues as
well as a discussion of incidents in which participants noticed over-
general thinking in everyday contexts. Session 5 involved further
practice using all cue types, revision of the material covered throughout
the treatment, and discussion of how to maintain what had been learnt
during MEST.
2.3.2. Psychoeducation and supportive counselling (PSC)
The PSC intervention followed the same format and length as the
MEST intervention (i.e., delivered by two therapists to groups of 5–8
individuals over 5×60min sessions). The PSC manual was developed
and manualized for this trial by two clinical psychologists (AWS, TD), in
consultation with two experienced counsellors from the Cambridge
University Counselling Service.
A non-judgemental, supportive environment was created whereby
participants were encouraged to discuss events and topics of their
choice. Through reflection and discussion, the aim was to support
members to better cope with everyday life. This approach employed
non-directive methods (such as drawing upon the therapeutic re-
lationship, encouraging input from group members, reflective lis-
tening), and avoided directive methods such as those taught in cogni-
tive behavioral therapy (e.g., cognitive restructuring). To optimize the
comparability between conditions, participants also kept a diary in
which they were asked to record material from each day that they may
wish to raise in the group. This material could involve positive, nega-
tive, or neutral daily events or themes. In Session 1, psychoeducation
about depressive symptoms was presented and the experience of group
members was normalized. Participants were invited to discuss what
they would like to get out of attending the group. An outline of the
programme was then provided and the homework tasks were in-
troduced. Session 2 involved reviewing the homework and continued
discussion of events that participants had noted down in their diaries,
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with therapists encouraging input from other group members. Sessions
3, 4, and 5, followed an identical structure – a homework review, fol-
lowed by discussion, with the homework task to record daily events or
themes for later discussion.
2.4. Treatment fidelity
After each session, therapists completed a Treatment Fidelity
Checklist which was developed specifically for this study and measured
compliance to the protocol. Fifteen percent of the audio-taped treat-
ment sessions (half from MEST and half from PSC) were randomly se-
lected and rated for adherence to the manual by an experienced clin-
ician (LJ), who was not involved in the day-to-day running of the trial.
Ratings (0–1) indicated that there was exceptionally high clinician
adherence to the manual (adherence=0.996).
2.5. Randomization and sequence generation
Participants were cluster randomized using a blocked procedure
with 5–8 participants per group using computer-generated quasi-
random numbers. Randomization was conducted at the start of the trial
by the trial statistician (PW) and communicated to trial managers
(AWS, CH) after participant groups had been recruited into the study.
2.6. Blinding
This was a single-blind study. All assessors and data analysts were
blind to participant condition. Participants were blind to condition until
the first treatment session where they were informed of their group
allocation.
2.7. Outcome measures
2.7.1. Memory specificity
Generated memories on the Autobiographical Memory Test were
audiotaped for later coding and the number of specific memories was
calculated. Assessors coded memories and a second-rater assessed a
randomly selected 15% of these tapes. Inter-rater reliability for speci-
ficity vs non-specificity was high (κ=0.99). We evaluated changes in
memory specificity from baseline to post-intervention and to three-
month follow-up, across groups.
2.7.2. Primary clinical outcome
The BDI-II (Beck et al., 1996) is a 21-item measure of depressive
symptoms and severity over the past two weeks, and has strong psy-
chometric properties. The primary endpoint was three-month follow-
up.
2.7.3. Secondary clinical outcomes
Secondary outcomes were depressive symptoms on the BDI-II at
post-intervention, and diagnostic status and depression-free days, at
post-test and follow-up. Diagnostic status and depression-free days were
measured using the Longitudinal Interview Follow-up Evaluation (LIFE;
First et al., 1995) to the SCID. Autobiographical memory specificity was
measured using the Autobiographical Memory Test (Williams &
Broadbent, 1986), as employed longitudinally by Brittlebank et al.
(1993). Generated memories were audiotaped for later coding and the
number of specific memories was calculated. Assessors coded memories
and a second-rater assessed a randomly selected 15% of these tapes.
Inter-rater reliability for specificity vs non-specificity was high
(κ=0.99).
2.7.4. Additional process outcomes
Process variables were measured to identify potential mechanisms
of change. Problem-solving was measured using the Means Ends
Problem Solving Task (MEPS; Platt & Spivack, 1975), which indexes the
number of steps used to solve a problem (means) and an overall ef-
fectiveness score out of 7 (Marx, Williams, & Claridge, 1992). A greater
number of means and higher effectiveness score reflect greater levels of
problem-solving ability. We administered a shortened version of the
MEPS (Scenarios 2, 4, 8, and 10) which is commonly used with de-
pressed samples (Watkins & Moulds, 2005). Rumination was measured
using the Ruminative Response Scale (RRS; Nolen-Hoeksema &
Morrow, 1991). Cognitive avoidance was measured using the Cognitive
Avoidance Questionnaire (CAQ; Sexton & Dugas, 2008), which is a 25-
item measure of the degree to which an individual engages in five
different cognitive avoidance strategies (thought suppression, thought
substitution, distraction, avoidance of threatening stimuli, and trans-
formation of images into thoughts). Executive function was measured
using the Controlled Oral Word Association Test (COWAT) to test
verbal fluency (VF), in which participants generate words in 60 s, be-
ginning with a particular letter (i.e., F, A or Spreen & Strauss, 1998).
Digit Span (DS) also tested executive function and is a subtest from the
Weschler Adult Intelligence Scale (Wechsler, 2014). Short term memory
was measured at baseline using the Verbal-Paired Associates task (VPA)
from the Weschler Memory Scale (Wechsler, 2009), to ensure that
groups did not differ on general memory functioning at baseline.
2.8. Procedure
Ethical approval was obtained from the UK National NHS Research
Ethics Service (East of England, 11/H0305/1). Recruitment began in
February 2014 and closed in April 2016. Prior to study entry, partici-
pants received an information sheet and provided written informed
consent before being screened for eligibility. The screening session in-
volved administration of the SCID-IV, the AMT and BDI-II. Eligible
participants were provided detailed study information and signed an-
other consent form in order to proceed into the trial.
Participants were tested individually in a quiet testing room by re-
searchers blind to group status on three occasions: at baseline, post-
treatment, and 3-month follow-up. The baseline assessment session
consisted of the AMT, MEPS, VF, DS, VPA, along with a questionnaire
package containing basic demographics, BDI-II, CAQ, and RRS. When a
minimum of five participants met inclusion criteria, the group was
cluster-randomized to either MEST or PSC. Following treatment, par-
ticipants were re-assessed (post) on all measures, in addition to mea-
suring the number of depression free days experienced since the be-
ginning of the intervention using the LIFE. All measures were re-
administered at three month follow-up. Task and questionnaire order,
MEPS scenarios and AMT wordlists were counterbalanced across as-
sessment sessions. Assessment sessions lasted between 45 and 60min
and participants were reimbursed at a rate of £6/hour for their time. A
6-month follow-up occurred via phone with participants allocated to
the MEST group only, during which participants completed the SCID-IV
Mood Module, number of depression free days on the LIFE, and re-
turned a completed BDI-II to the experimenter. No adverse events were
reported during the trial.
3. Results
3.1. Sample characteristics
Of the 156 participants assessed for eligibility, 62 met inclusion
criteria. Participants were cluster randomized to either MEST (n=31)
or PSC (n=31). The CONSORT flow chart outlines recruitment, ran-
domization, and completion (see Fig. 1). Sample characteristics for
randomized participants are shown in Table 1. The mean age of the
sample was 41.77 years (SD=13.6), and 66% of participants were
female. Approximately half of the sample were university educated and
employed at the time of the study. Sixty percent reported taking med-
ication for depression, and 25% were receiving psychological treat-
ment. All had a history of recurrent depression. Twenty seven
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participants (43%) had experienced too many prior depressive episodes
to distinguish the exact number (coded as ‘too many to count’ on the
SCID). For those able to distinguish the number of prior episodes, the
mean was 5.03 (SD=3.05). Forty percent of participants also met
criteria for a comorbid disorder (as indexed by the SCID). Current co-
morbid diagnoses were generalised anxiety disorder (n=14), post-
traumatic stress disorder (n=8), obsessive compulsive disorder
(n=3), social anxiety disorder (n=9), specific phobia (n=2), panic
disorder (n=4), and eating disorder (n=3).
At baseline, participants reported depressive symptoms in the severe
range on the BDI-II and recalled an average of 5.2 specific memories out
of a possible twelve memories (43% specific) on the AMT. There were
no differences between the PSC and MEST conditions at baseline on
demographic variables, depressive symptoms, number of prior depres-
sive episodes, cognitive avoidance, rumination, memory specificity,
problem-solving ability, working memory or short-term memory (all
ps > .05). However, the MEST group performed better on the verbal
fluency task (p= .03), and baseline performance was therefore cov-
aried in all subsequent analyses in line with the trial protocol (Dalgleish
et al., 2014).
Fig. 1. CONSORT flow chart.
Table 1
Sample characteristics at baseline for the Memory Specificity Training (MEST) and
Psychoeducation and Supportive Counselling (PSC) conditions.
PSC MEST χ2 p
(n= 31) (n= 31)
Gender (% female) 61.3% 70.1% 0.6 .592
Educationa 3:7:10:5:6 5:7:7:11:1 6.7 b .152
Employment (% employed) 48.4% 41.9% 0.3 .799
Taking medication (%) 61.3% 58.1% 0.7 1.00
Receiving psychotherapy (%) 29.0% 22.5% 0.3 .772
M (SD) M (SD) t p
Age 39.1 (11.3) 44.45 (15.3) −1.6 .123
BDI-II 32.9 (9.7) 30.6 (11.2) 0.9 .387
Verbal paired associates recall 16.2 (9.0) 19.2 (9.0) −1.3 .208
Digit span 16.9 (4.8) 19.1 (4.5) −1.8 .070
a Highest level of education attained (5th form; 6th form; undergraduate; post-
graduate; other).
b Fishers Exact Test; *p < .05.
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3.2. Treatment characteristics
Attrition was 11% at post-intervention and 20% at the 3-month
follow-up (the primary endpoint) in line with pre-trial estimates
(Dalgleish et al., 2014). These figures include three participants (5%)
who withdrew prior to attending the first treatment session (in the PSC
condition). There was no differential drop-out between the groups at
either post-treatment, χ2 (62)= 2.30, p= .130, or 3-month follow up,
χ2 (62)= 0.11, p=1.00. Participants completed a mean of 3.72 of the
five treatment sessions (median=5 sessions), again with no difference
in the mean number of sessions attended between groups, χ2
(5)= 0.23, p= .216.
After completing the first session, participants in the MEST condi-
tion reported greater ratings for how logical the intervention seemed
(M=7.25, SD=1.45) than the PSC participants (M=5.54,
SD=1.82), t (48)= 3.66, p < .001, d=1.04. MEST (M=5.75,
SD=1.75) was also perceived to be more likely to be successful in
reducing symptoms than PSC (M=4.27, SD=20.1), t (48)= 2.77,
p= .01, d=0.78. There was no significant difference between the in-
terventions in how confident participants were in recommending the
program to a friend, t (48)= 0.86, p= .396, d=0.24, or in how much
improvement participants expected in their depressive symptoms, t
(48)= 0.43, p= .673, d=0.12.
3.3. Analysis of trial outcomes
All analyses were initially completed on an intent-to-treat (ITT)
basis, using multiple imputation to account for missing data. Results did
not vary between ITT and per protocol analyses (for participants who
attended three of the five sessions). As such, only ITT analyses are re-
ported. We completed mixed-model repeated measures (MMRM) ana-
lyses (Hamer & Simpson, 2009) with intervention type and time as fixed
factors, and individual group allocation as a random effect to evaluate
and accommodate clustering effects. We also covaried for verbal flu-
ency to account for the observed difference at baseline. These analyses
produced estimated marginal means and standard errors (Table 2),
along with F values for between group contrasts at each time point, and
these F values were used to calculate Cohen's d's. Positive values de-
monstrate an effect in favor of the MEST condition. 95% confidence
intervals are presented for the d for primary and secondary outcomes.
As this was a pilot trial in preparation for a fully-powered, definitive
trial, key outcomes of interest are the obtained effect sizes and their
associated confidence intervals (which reflects the likely size and
variability of treatment effects), rather than statistical significance of
the comparisons (Lancaster et al., 2004; NIHR, 2017).
3.3.1. Memory specificity
The therapeutic target of MEST is to improve memory specificity,
and results demonstrated that the intervention achieved this aim (see
Table 2). Analyses revealed a group by time interaction for memory
specificity, F (1, 107.2)= 5.96, p= .004, d=0.62. As anticipated, a
large between-group effect-size indicated that participants in the MEST
group demonstrated greater levels of memory specificity compared to
the PSC group at both post-test, F (1, 127.34)= 11.90, p= .001,
d=0.88 [0.34, 1.42], and follow-up, F (1, 132.90)= 8.49, p= .004,
d=0.74 [0.21, 1.27]. There was a large within-group effect size for
change in specificity in the MEST condition from pre-to post-test
(d=1.53).
3.3.2. Primary clinical outcomes
Changes in depression characteristics are presented in Table 2 and
Fig. 2. The primary outcome was BDI-II score at three month follow-up.
A mixed effects model with the above specifications indicated that
across groups there was a significant reduction in depressive symptoms
over time, F (2, 102.5)= 17.5, p < .001, but no effect of group, F (1,
59.75)= 0.07, p= .79, nor a time× group interaction, F (2,
102.6)= 0.46, p= .63. On average, participants experienced a de-
crease from the severe to moderate range on the BDI-II (Beck et al.,
1996) from baseline (M=31.74, SD=10.47) to follow-up (M=23.74,
SD=14.14), t (102.8)= 3.41, p= .001, d=0.87. However, a negli-
gible between-group effect size was found at three month follow-up, F
(1, 94.11)= 0.03, p= .86, d=0.04 [-0.48, 0.56].
3.3.3. Secondary clinical outcomes
Our co-secondary outcomes were BDI-II score at post-test, diag-
nostic status, and depression free days at post-test and three month
follow-up. The mixed effects model predicting BDI-II demonstrated a
small and non-significant between-group effect size in favor of the
MEST group at post-test (see Table 2), F (1, 90.70)= 0.15, p= .70,
Table 2
Estimated marginal means and standard error (SE) for primary, secondary outcomes at each time point, and pre to post change in process measures by condition.
Outcome Psychoeducation & Supportive Counselling Memory Specificity Training
Baseline Post 3 months Baseline Post 3 months
Mean (SE) Mean (SE) Mean (SE) Mean (SE) Mean (SE) Mean (SE)
BDI-II depression score 32.6 (2.3) 27.04 (2.4) 24.1 (2.4) 30.8 (2.3) 25.8 (2.3) 24.7 (2.3)
AMT specific 5.2 (0.4) 5.8 (0.5) 6.6 (0.5) 5.2 (0.4) 8.0 (0.4) 8.5 (0.5)
Days depression free (proportion) – – .39 (.07) .40 (09) – – .40 (.06) .49 (.07)
Remission rate – – 42.3% – 52.0% – – – 34.5% – 61.5% –
Rumination 62.2 (12.1) 57.36 (2.51) 60.77 (4.58) 59.6 (12.7) 57.02 (2.32) 53.28 (4.30)
Cognitive avoidance 74.2 (20.4) 69.09 (4.42) 74.43 (24.01) 71.3 (20.4) 64.05 (4.16) 68.84 (25.08)
Problem solving - means 4.4 (2.6) 3.87 (0.56) – – 4.8 (2.2) 5.88 (0.53) – –
Problem solving- effectiveness 5.4 (3.2) 5.14 (0.58) – – 6.6 (2.9) 6.63 (0.55) – –
Verbal fluency 11.9 (6.0)a 13.67 (0.97) 12.55 (0.95) 15.1 (5.3) 15.71 (0.91) 16.97 (0.93)
Note. Estimated marginal means are estimated from a mixed-model with group number as a random effect (to account for clustering effects) and intervention condition and time as fixed
effects, covarying for verbal fluency to account for group difference in verbal fluency at baseline. Note that verbal fluency was not covaried when analysing change in process measures.
a Verbal fluency differed between groups at baseline, t=-2.3, p = .03.
Fig. 2. Mean (± 1 SEM) depressive symptoms at post-intervention and 3-month follow-
up for MEST and PSC groups.
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d=0.10, [-0.42, 0.62]. There was also a small, non-significant be-
tween-group effect size in favor of MEST in the relative number of
participants who no longer met criteria for a Major Depressive Episode
at both post-test, F (1, 89)= 0.76, p= .38, d=0.22 [-0.34, 0.78], and
follow-up, F (1, 89)= 0.35, p= .55, d=0.15 [-0.43, 0.73].2 The 6-
month follow-up assessment of the MEST group indicated that im-
provement in BDI-II was maintained from 3 to 6 months post-treatment
(M=23.26, SD=13.87), t (18)= 1.38, p= .19, and that 52% of in-
dividuals no longer met criteria for a Major Depressive Episode at 6
months post-treatment.
Similarly, there was a negligible non-significant between-group ef-
fect size in favor of MEST for the difference in proportion of depression-
free days experienced from pre-to post-test, F (1, 8)= 0.20, p= .66,
d=0.11 [-0.41, 0.63]. This was also the case for depression free days
from post-test to follow-up, F (1, 9.11)= 0.08, p= .78, d=0.07
[-0.44, 0.59]. At 6-months, MEST participants reported an average
proportion of .55 (SE=0.30) depression free days in the period since
the three-month follow-up.
3.3.4. Additional process outcomes
We also explored whether MEST and PSC differentially impacted the
degree of change in the process variables: rumination; problem solving;
cognitive avoidance; and verbal fluency (an index of executive control).
A Bonferroni correction was applied to account for multiple compar-
isons (α=0.05/5, corrected p= .01). Trivial to small (Cohen, 1992)
non-significant between-group effect sizes (descriptive statistics in
Table 2) were observed on pre-to post-intervention change in rumina-
tion, F (1, 46)= 0.14, p= .71, d=0.11, cognitive avoidance, F (1,
44)= 0.05, p= .82, d=0.06, and verbal fluency, F (1, 48)= 0.48,
p= .79, d=0.19. For problem solving ability, there was a moderate
between-group effect size in favor of the MEST group for the number of
means (or steps) used to solve a problem, F (1, 46)= 5.95, p= .02,
d=0.68. A trivial between-group effect size was observed for effec-
tiveness of problem solving, F (1, 46)= 0.18, p= .67, d=0.12.
3.4. Exploratory analyses
We next explored whether group-based change in memory specifi-
city from pre-to post-test would underlie improvement in depressive
symptoms at follow-up. This hypothesis was not supported,
ΔR2= 0.024, F (1, 45)= 2.05, p= .16. Similarly, change in specificity
did not significantly impact BDI-II at follow-up (adjusting for BDI-II at
pre-intervention), across all participants (β=−.51, p= .176), nor in
the in the MEST group alone (β=0.11, p= .287).
We also explored whether change in problem solving skills, rumi-
nation, cognitive avoidance, or verbal fluency mediated the effect of
group on BDI-II at follow-up creating 1000 bootstrapped samples in
PROCESS (Hayes, 2013). All 95% confidence intervals for indirect ef-
fects spanned zero, and thus demonstrated no significant mediations.
4. Discussion
The core aim of this pilot RCT was to assess the effects of MEST on
our cognitive target of memory specificity and on a range of clinical
measures of depression, relative to an active psychoeducation and
support counselling (PSC) intervention, to provide a platform for a later
definitive trial. As anticipated, MEST (but not PSC) delivered large ef-
fects for change (d=0.88 at post, d=0.74 at follow-up) on our target
cognitive mechanism variable of memory specificity. Furthermore, on
our primary clinical endpoint of self-reported depressive symptoms at
three-month follow-up, both MEST and PSC led to a large decrease in
symptoms from the severe range on the BDI-II on average at baseline, to
the moderate range at follow-up (d = 0.87). Data available from the
MEST participants at six-month follow-up also indicated that their
improvement in depressive symptoms was maintained.
However, we found no support for MEST being a clinically superior
intervention to PSC, with a negligible effect size difference between the
treatment arms on our primary outcome (d=0.04). Secondary de-
pressive outcomes largely mirrored this finding, with negligible to small
between-group effects in favor of MEST (ds from 0.07 to 0.22) for de-
pressive symptoms at post-intervention, for the number of participants
meeting criteria for MDD, and for the number of depression-free days
experienced, at both post-test or three-month follow-up. Taken to-
gether, the results provide no support that MEST is likely to be superior
to PSC in the amelioration of depression. That is, the data suggest that
MEST does not provide any additional benefits over and above that
offered by existing treatments for depression such as PSC. Although
MEST delivered superior effect sizes for change in memory specificity
relative to PSC, we found no support in our exploratory analyses that
changes in our target process mediated clinical outcomes in the trial.
This is perhaps unsurprising due to the relatively small sample size, the
negligible difference between the treatment arms on the clinical end-
point, and that the current study was underpowered to detect sig-
nificant group differences between conditions. Any fully-powered de-
finitive trial would need to explore the role of specificity as a
mechanism of change. The failure of memory specificity to mediate
clinical outcomes suggests that the causal relationship between memory
specificity and depressive symptoms may be more complex than pre-
viously indicated. Therefore, it will be important for future studies to
investigate the process through which specificity influences depressive
symptoms. We found no support for superior effects of MEST relative to
PSC on our other process measures.
If we consider the pre-post within-arm effect size for the effects of
MEST on depressive symptoms in the current study (d=2.65 at three-
month follow-up), we find that it is actually larger than that found in
our pilot RCT (Neshat-Doost et al., 2013; d=0.47 at two-month follow-
up). However, the pilot trial assessed MEST against a no-intervention
control condition, whereas in the current study the comparison inter-
vention comprised an active treatment. The use of an active comparator
group in controlled trials evaluating psychotherapy for depression has
been found to be associated with small effect sizes and non-significant
results, particularly in high quality trials involving manualized treat-
ment, therapist training and supervision, and therapist fidelity checks
(Mohr et al., 2014). Furthermore, active control groups that are mat-
ched to the experimental group in terms of treatment length, credibility
and implementation often have a considerable impact on treatment
outcome (Mohr et al., 2008). Therefore, while inclusion of an active
comparison intervention controls for non-specific treatment factors
such as contact with a supportive mental health professional, and ex-
posure to beneficial group processes and peer support, it nonetheless
makes it very challenging to show superiority of the experimental
group. The inclusion of a non-active control group such as a waitlist
control or treatment as usual group would have uncovered the extent to
which MEST and PSC were useful in the treatment of depression in a UK
healthcare context, in line with our previous small pilot trial of MEST
conducted outside of the UK (Neshat-Doost et al., 2013). This represents
a limitation of the current study and in order to illustrate the extent to
which these active interventions are efficacious, any future trials should
include both active and non-active control groups, in the same study.
The decrease in symptoms following MEST from the severe to
moderate range on the BDI-II, reflecting a minimally clinically sig-
nificant symptom improvement of 20% from baseline BDI scores
(Button et al., 2015; Viljoen, Iverson, Griffiths, & Woodward, 2003),
along with the low drop-out rate (16%) provides preliminary evidence
that MEST may be useful as a low-intensity intervention. Although our
findings indicate that MEST does not improve upon current treatment
options for depression, it may still hold value as a programme that shifts
2 It is possible that the use of self-report measures as our primary and secondary clinical
outcomes may have influenced results due to their reliance on memory. However, the
effect sizes were mirrored in the clinician-administered measure of depression status.
A. Werner-Seidler et al. Behaviour Research and Therapy 105 (2018) 1–9
7
an additional risk factor for relapse (memory specificity) that can be
delivered in group format by non-specialists with minimal training. Any
future work to evaluate MEST should be completed by research groups
who have not been involved in the development of the programme, to
address researcher allegiance, and prior to any definitive trial, more
work is needed to elucidate the processes through which memory
specificity impacts depressive symptoms.
The lack of support for any difference between MEST and PSC in-
dicates that any further evaluation of MEST should investigate MEST's
non-inferiority, rather than superiority. That is, we recommend that the
next step in this line of enquiry be to conduct a powered non-inferiority
trial which compares MEST to established evidence-based group
treatments for depression such as PSC or CBT (Cuijpers et al., 2012;
Okumura & Ichikura, 2014). PSC requires highly skilled therapists who
can provide a safe and non-judgemental environment for their clients to
discuss the causes of their distress. CBT also requires highly skilled
therapists to deliver structured skills-based therapy which teaches cli-
ents how to challenge automatic, depressogenic patterns of thought and
re-engage with the world that they have often withdrawn from. Such a
trial should also include a robust health economics analysis to examine
the cost-effectiveness of MEST relative to comparison interventions. If
MEST were found to be more cost-effective and non-inferior in treat-
ment effects to either of these interventions, the advantage would be
that it is of lower intensity, requiring less specialised clinical training
and characterized by greater simplicity in delivery.
Trial registration
NCT01882452 (ClinicalTrials.gov).
Protocol published
www.trialsjournal.com/content/15/1/293.
Funding
MC_US_A060_0019, Medical Research Council, UK.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://dx.
doi.org/10.1016/j.brat.2018.03.004.
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